Molecular analysis of network vulnerability to α-synuclein pathology reveals PAKs as therapeutic targets for Parkinson’s disease is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Aligning Science Across Parkinson's
Grant: ASAP-020616
Understanding and manipulating cellular and circuit-level vulnerability to neurodegeneration in Parkinson’s disease
National Institutes of Health
Grant: R21-NS116255
Van Andel Institute West Michigan Neurodegenerative Disease (MiND) Program, Grand Rapids, MI
Grant: pathway-to-independence award
National Institutes of Health
Grant: 7R21NS116255-02
Investigating the role of MARKs in Parkinson's disease pathogenesis
Fields of Study
Immunofluorescence Imaging Dataset Supporting the Molecular Analysis of Network Vulnerability to α-Synuclein Pathology and PAKs as Therapeutic Targets in Parkinson’s Disease